The A-BOM alliance is a community of foundations, corporations, scientists andresearchers. Through initial discussions with families and experts, we identified the symptoms of Angelman syndrome which have the most impact on patients and their families. We are focusing our search for biomarkers and outcome measures to these areas. These areas of concentration are patient-centered and clinically relevant.
Focus areas for Angelman Syndrome Biomarkers and Outcome Measures